Given the upregulation of STAT3 in several cancers, the upregulation of thioredoxin 1 in its reduced form in neoplastic tissues is undesirable, as it will prompt downstream signaling mediated by STAT3 [26]. The gene discussed is STAT3; the disease is cancer.